Skip to main content
. 2017 Aug 24;38(11):1475–1485. doi: 10.1038/aps.2017.116

Figure 3.

Figure 3

BCR-ABL1 is exogenously expressed by K562-MV-MSCs with enhanced proliferation. (A) BM-MSCs treated with different concentrations of K562-MVs from 0 to 1000 ng/mL, and cell proliferative activity was observed. BM-MSCs treated with K562-MVs at 200 to 1000 ng/mL show enhanced proliferation with the compared results shown as nsP>0.05; **P<0.01; n=6. Bars, SD. (B) Chromosomal analysis of BM-MSCs treated with K562-MVs at 800 ng/mL for 72 h. No formed aberrant chromosomes can be observed, n=3.